Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Tuesday 12 May, 2020

JP Morgan Sec LLC

Willis Towers Watson plc 8.3

RNS Number : 6673M
J.P. Morgan Securities LLC
12 May 2020
 

Ap19

 

 

FORM   8.3

 

IRISH TAKEOVER PANEL 

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

J.P. Morgan Securities LLC

Companydealtin

Willis Towers Watson plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

US$0.000304635 ordinary shares

Date of dealing

11 May 2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1)Relevantsecurities

 819,581  0.64

1,310,952  1.02

(2) Derivatives (other than options)

 684,663  0.53

762,686  0.59

(3)Optionsandagreementstopurchase/sell

 

 

Total

 1,504,244  1.17

2,073,638  1.61

             

 

 

Ap20

 

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

 

 

Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit  (USD)

 

(Note 5)

 

Purchase

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sale

73

100

106

502

6,275

900

3,433

1,166

16

479

298

81

100

19

100

100

37

36

10

100

 

73

106

100

200

211

133,624

71

93

5

900

3,433

1,166

2,995

1,000

73

197.3500

199.3700

199.4100

199.8629

200.0000

200.1789

200.2091

200.2196

200.4000

200.8119

200.9676

201.2523

201.3929

201.4050

201.4722

201.5750

201.5900

201.7308

201.7600

201.8750

 

197.3500

199.4100

199.5200

199.8250

199.8264

200.0000

200.0005

200.0050

200.0200

200.1789

200.2091

200.2196

200.2659

200.3060

201.0450

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 6)

Numberofrelevantsecurities

(Note 7)

Priceperunit   (USD) (Note 5)

Equity Swap

Long

 

 

 

Short

126,512

3,433

1,166

 

900

200.0000

200.2091

200.2196

 

200.1789

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 5)

 

 

 

 

 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

Ap21

 

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any 
relevant securities to which any derivative referred to on this form is referenced. If none, this
should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)    NO

 

Dateofdisclosure

12 May 2020

Contact name

Alwyn Basch

Telephone number

0207 742 7407

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

N/A

If aconnectedEFM,statenatureofconnection (Note 10)

N/A

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISELLLFFBELBBBZ

a d v e r t i s e m e n t